P. De Wals

发表

Measuring the intensity of pregnancy planning effort.

M. Moos, Pascale Morin, H. Payette, 2003, Paediatric and perinatal epidemiology.

Impact of folic acid food fortification on the birth prevalence of lipomyelomeningocele in Canada.

Jane A. Evans, T. Niyonsenga, P. De Wals, 2008, Birth defects research. Part A, Clinical and molecular teratology.

Reduction in neural-tube defects after folic acid fortification in Canada.

Jane A. Evans, T. Niyonsenga, P. De Wals, 2007, The New England journal of medicine.

Policy making for vaccine use as a driver of vaccine innovation and development in the developed world.

Fangjun Zhou, Walter A Orenstein, Katherine Seib, 2017, Vaccine.

Predictors of hospitalization for lower respiratory tract infection in children aged <2 years in the province of Quebec, Canada

P. De Wals, G. Deceuninck, R. Gilca, 2015, Epidemiology and Infection.

International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines.

Tao Zhang, Jan Bonhoeffer, Harald Heijbel, 2013, Vaccine.

Influenza-like illness during pregnancy: results from a study in the eastern townships, Province of Quebec.

P. De Wals, J. Moutquin, E. Frost, 2003, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

Meningococcal disease in Belgium. Secondary attack rate among household, day-care nursery and pre-elementary school contacts.

P. De Wals, M. Lechat, L. Hertoghe, 1981, The Journal of infection.

Surveillance of Invasive Streptococcus pneumoniaeInfection in the Province of Quebec, Canada, from 1996 to 1998: Serotype Distribution, Antimicrobial Susceptibility, and Clinical Characteristics

P. De Wals, R. Allard, V. Loo, 2001, Journal of Clinical Microbiology.

Evaluation of several approaches to immunize parents of neonates against B. pertussis.

P. De Wals, F. Audibert, P. Ovetchkine, 2013, Vaccine.

A DELPHI study on aspects of study design to overcome knowledge gaps on the burden of disease caused by serogroup B invasive meningococcal disease

M. Bullinger, P. De Wals, D. Bloom, 2019, Health and Quality of Life Outcomes.

Home care as an alternative to hospitalization: a case study in Belgium.

P. De Wals, L. Gunning-Schepers, X. Leroy, 1984, Social science & medicine.

Estimating the number needed to vaccinate to prevent diseases and death related to human papillomavirus infection

P. De Wals, M. Boily, M. Brisson, 2007, Canadian Medical Association Journal.

Spina bifida before and after folic acid fortification in Canada.

Jane A. Evans, T. Niyonsenga, P. De Wals, 2008, Birth defects research. Part A, Clinical and molecular teratology.

How to compare the efficacy of conjugate vaccines to prevent acute otitis media?

M. Pichichero, P. De Wals, L. Erickson, 2009, Vaccine.

Pediatric Pleural Empyema in the Province of Quebec: Analysis of a 10-Fold Increase Between 1990 and 2007.

P. De Wals, C. Quach, P. Ovetchkine, 2014, Journal of the Pediatric Infectious Diseases Society.

Validity of the recording of meningococcal disease according to various sources of information.

P. De Wals, M. Verlinden, M. Lechat, 1984, The Journal of infection.

Burden of rotavirus disease: A population-based study in Eastern Townships, Quebec.

P. De Wals, L. Valiquette, C. Cyr, 2013, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

Invasive Serogroup B Neisseria meningitidis in Québec, Canada, 2003 to 2010: Persistence of the ST-269 Clone Since It First Emerged in 2003

B. Lefebvre, P. De Wals, R. Tsang, 2012, Journal of Clinical Microbiology.

Impact of an Immunization Campaign to Control an Increased Incidence of Serogroup B Meningococcal Disease in One Region of Quebec, Canada

B. Lefebvre, P. De Wals, G. De Serres, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection

P. De Wals, D. Caugant, S. Sidorenko, 2017, Expert review of vaccines.

Invasive Meningococcal Disease in Québec, Canada, Due to an Emerging Clone of ST-269 Serogroup B Meningococci with Serotype Antigen 17 and Serosubtype Antigen P1.19 (B:17:P1.19)

P. De Wals, R. Tsang, W. Zollinger, 2006, Journal of Clinical Microbiology.

Cost-effectiveness Comparison of Monovalent C Versus Quadrivalent ACWY Meningococcal Conjugate Vaccination in Canada

P. De Wals, Zhou Zhou, 2017, The Pediatric infectious disease journal.

Quality of care in unlicensed homes for the aged in the eastern townships of Quebec.

P. De Wals, A. Emond, M. Dubois, 1999, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Pneumonia epidemic caused by a virulent strain of Streptococcus pneumoniae serotype 1 in Nunavik, Quebec.

P. De Wals, M. Libman, J. Proulx, 2002, Canada communicable disease report = Releve des maladies transmissibles au Canada.

Epidemiology of Guillain-Barré Syndrome in the Province of Quebec

P. De Wals, M. Ouakki, G. Deceuninck, 2008, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Risk of Guillain-Barré syndrome following serogroup C meningococcal conjugate vaccine in Quebec, Canada.

P. De Wals, M. Ouakki, G. Deceuninck, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Hospitalizations for lower respiratory tract infections in children in relation to the sequential use of three pneumococcal vaccines in Quebec

P. De Wals, G. Deceuninck, R. Gilca, 2020, Canadian Journal of Public Health.

Forecasting Trends in Invasive Pneumococcal Disease among Elderly Adults in Quebec

B. Lefebvre, P. De Wals, G. Deceuninck, 2017, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

Impact of a mass vaccination campaign against Serogroup B meningococcal disease in the Saguenay-Lac-Saint-Jean region of Quebec four years after its launch.

B. Lefebvre, P. De Wals, G. De Serres, 2019, Vaccine.

Modeling the impact of a new vaccine on pneumococcal and nontypable Haemophilus influenzae diseases: a new simulation model.

P. De Wals, S. Black, R. Borrow, 2009, Clinical therapeutics.

Risk of Narcolepsy Associated with Inactivated Adjuvanted (AS03) A/H1N1 (2009) Pandemic Influenza Vaccine in Quebec

A. Desautels, E. Mignot, J. Montplaisir, 2014, PloS one.

Recent advances in the prevention of meningococcal B disease: Real evidence from 4CMenB vaccination

P. De Wals, F. Martinón-Torres, R. Bekkat-Berkani, 2021, Vacunas (English Edition).

Recent advances in meningococcal B disease prevention: real-world evidence from 4CMenB vaccination: Real-world effectiveness of MenB vaccination.

R. Rappuoli, P. De Wals, H. Marshall, 2021, The Journal of infection.

The Changing Epidemiology of Meningococcal Disease in Quebec, Canada, 1991–2011: Potential Implications of Emergence of New Strains

B. Lefebvre, P. De Wals, M. Douville-Fradet, 2012, PloS one.

Invasive pneumococcal diseases in birth cohorts vaccinated with PCV-7 and/or PHiD-CV in the province of Quebec, Canada.

B. Lefebvre, P. De Wals, G. Deceuninck, 2012, Vaccine.

A Longitudinal Epidemiology Study of Meningococcal Carriage in Students 13 to 25 Years Old in Quebec

P. De Wals, N. Kitchin, K. Jansen, 2018, mSphere.

Commentary on paradoxical observations pertaining to the impact of the 13-valent pneumococcal conjugate vaccine on serotype 3 Streptococcus pneumoniae infections in children.

P. De Wals, 2018, Vaccine.

Meningococcal disease in North America: Updates from the Global Meningococcal Initiative.

P. De Wals, L. Harrison, Henju Marjuki, 2022, The Journal of infection.

Effectiveness of Serogroup C Meningococcal Conjugate Vaccine: A 7-Year Follow-up in Quebec, Canada

B. Lefebvre, P. De Wals, G. De Serres, 2011, The Pediatric infectious disease journal.

Estimated Protection of Prior SARS-CoV-2 Infection Against Reinfection With the Omicron Variant Among Messenger RNA–Vaccinated and Nonvaccinated Individuals in Quebec, Canada

D. Skowronski, P. De Wals, M. Brisson, 2022, JAMA network open.

Relative efficacy of different immunization schedules for the prevention of serogroup C meningococcal disease: a model-based evaluation.

P. De Wals, J. Pépin, Pierre Trottier, 2006, Vaccine.

Methods for estimating the duration of bacterial carriage.

P. De Wals, P. Wals, A. Bouckaert, 1985, International journal of epidemiology.

Epidemiological and economic burden of pneumococcal diseases in Canadian children.

P. De Wals, T. Tam, M. Guay, 2003, The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses.

Effectiveness of a mass immunization campaign using serogroup C meningococcal conjugate vaccine.

P. De Wals, G. De Serres, G. Deceuninck, 2004, JAMA.

Serotype Distribution of Remaining Pneumococcal Meningitis in the Mature PCV10/13 Period: Findings from the PSERENADE Project

S. Zeger, P. De Wals, L. Hammitt, 2021, Microorganisms.

Possible Impact of Wide-scale Vaccination Against Serogroup B Neisseria Meningitidis on Gonorrhea Incidence Rates in One Region of Quebec, Canada

B. Lefebvre, P. De Wals, J. Longtin, 2017, Open Forum Infectious Diseases.

E. Sanders, P. De Wals, M. Knol, 2021, Vaccine.

Impact of 2+1 pneumococcal conjugate vaccine program in the province of Quebec, Canada.

B. Lefebvre, P. De Wals, M. Douville-Fradet, 2014, Vaccine.

Characterization of invasive Neisseria meningitidis strains from Québec, Canada, during a period of increased serogroup B disease, 2009-2013: phenotyping and genotyping with special emphasis on the non-carbohydrate protein vaccine targets

B. Lefebvre, P. De Wals, R. Tsang, 2015, BMC Microbiology.

Incidence of invasive pneumococcal disease before and during an era of use of three different pneumococcal conjugate vaccines in Quebec.

B. Lefebvre, P. De Wals, J. Longtin, 2018, Vaccine.

Comparative Long Term Immunogenicity of Two Recombinant Hepatitis B Vaccines and the Effect of a Booster Dose Given After Five Years in a Low Endemicity Country

P. De Wals, G. De Serres, V. Gilca, 2005, The Pediatric infectious disease journal.

Antibody persistence and the effect of a booster dose given 5, 10 or 15 years after vaccinating preadolescents with a recombinant hepatitis B vaccine.

P. De Wals, M. Dionne, G. De Serres, 2013, Vaccine.

The burden of pneumococcal disease in the Canadian population before routine use of the seven-valent pneumococcal conjugate vaccine.

P. De Wals, M. Guay, L. Erickson, 2007, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

[Methods for analyzing the frequency, prevalence and the duration of asymptomatic carriage of Neisseria meningitidis. Longitudinal study of a school population in Belgium].

P. De Wals, S. De Maeyer, C. Gilquin, 1982, Medecine tropicale : revue du Corps de sante colonial.

Biopsychosocial determinants of pregnancy length and fetal growth.

T. Niyonsenga, P. De Wals, J. Moutquin, 2008, Paediatric and perinatal epidemiology.

Prevalence of middle ear abnormalities from otitis media in relation with pneumococcal vaccine use in the Inuit population of Nunavik, province of Quebec, Canada.

P. De Wals, H. Ayukawa, J. Proulx, 2018, Vaccine.

New vaccines offering a larger spectrum of protection against acute otitis media: will parents be willing to have their children immunized?

P. De Wals, È. Dubé, M. Ouakki, 2009, International journal of pediatric otorhinolaryngology.

Mortality in meningococcal disease in Belgium.

P. De Wals, M. Lechat, L. Hertoghe, 1984, The Journal of infection.

Prevalence of neural tube defects in the province of Quebec, 1992.

P. De Wals, P. Wals, L. Pinsonneault, 1999, Canadian journal of public health = Revue canadienne de sante publique.

Association between holoprosencephaly and exposure to topical retinoids: results of the EUROCAT Survey.

E. Calzolari, P. De Wals, M. Cornel, 1991, Paediatric and perinatal epidemiology.

Vaccinating adolescents against meningococcal disease in Canada: a cost-effectiveness analysis.

P. De Wals, L. Coudeville, L. Erickson, 2007, Vaccine.

Chromosomal anomalies and Chernobyl.

P. De Wals, I. de la Mata, M. Lechat, 1988, International journal of epidemiology.

A postpartum vaccination promotion intervention using motivational interviewing techniques improves short-term vaccine coverage: PromoVac study

P. De Wals, L. Valiquette, N. Carrier, 2018, BMC Public Health.

Preadolescent non- and hyporesponders following three doses of hepatitis B vaccine need only one more dose.

P. De Wals, G. De Serres, N. Boulianne, 2002, Vaccine.

Heterogeneity of neural tube defects in Europe: the significance of site of defect and presence of other major anomalies in relation to geographic differences in prevalence.

A. Cuschieri, E. Garne, Y. Gillerot, 1991, Teratology.

Comparison of Phenotypic and Genotypic Approaches to Capsule Typing of Neisseria meningitidis by Use of Invasive and Carriage Isolate Collections

P. De Wals, K. Jansen, L. Mayer, 2015, Journal of Clinical Microbiology.

The potential cost-effectiveness of prophylactic human papillomavirus vaccines in Canada.

P. De Wals, M. Boily, M. Brisson, 2007, Vaccine.

Risk and prevention of meningococcal disease among education workers: A review.

P. De Wals, L. Goulet, G. De Serres, 2004, The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses.

The potential cost-effectiveness of vaccination against herpes zoster and post-herpetic neuralgia

P. De Wals, M. Brisson, C. Quach, 2008, Human vaccines.

Global Landscape Review of Serotype-Specific Invasive Pneumococcal Disease Surveillance among Countries Using PCV10/13: The Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE) Project

P. De Wals, L. Hammitt, J. Scott, 2021, Microorganisms.

Hospitalisation for lower respiratory tract infection in children in the province of Quebec, Canada, before and during the pneumococcal conjugate vaccine era

P. De Wals, G. Deceuninck, R. Gilca, 2017, Epidemiology and Infection.

Effectiveness of three pneumococcal conjugate vaccines to prevent invasive pneumococcal disease in Quebec, Canada.

P. De Wals, G. De Serres, G. Deceuninck, 2016, Vaccine.

Effectiveness of three pneumococcal conjugate vaccines to prevent invasive pneumococcal disease in Quebec, Canada.

B. Lefebvre, P. De Wals, G. De Serres, 2016, Vaccine.

The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: Epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations

P. De Wals, D. Caugant, R. Steffen, 2019, Expert review of vaccines.

Overview of knowledge, attitudes, beliefs, vaccine hesitancy and vaccine acceptance among mothers of infants in Quebec, Canada

P. De Wals, È. Dubé, D. Gagnon, 2018, Human vaccines & immunotherapeutics.

An analytical framework for immunization programs in Canada.

P. De Wals, L. Farand, L. Erickson, 2005, Vaccine.

Modeling the impact of one- and two-dose varicella vaccination on the epidemiology of varicella and zoster.

P. De Wals, M. Brisson, G. De Serres, 2010, Vaccine.

Complications and sequelae of meningococcal disease in Quebec, Canada, 1990-1994.

P. De Wals, L. Erickson, P. Wals, 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, Canada

C. Fjell, D. Skowronski, L. Hoang, 2021, medRxiv.

Effectiveness of Pneumococcal Conjugate Vaccine Using a 2+1 Infant Schedule in Quebec, Canada

P. De Wals, G. De Serres, G. Deceuninck, 2010, The Pediatric infectious disease journal.

Trend in prevalence of neural tube defects in Quebec.

Pascale Morin, T. Niyonsenga, P. De Wals, 2003, Birth defects research. Part A, Clinical and molecular teratology.

Burden of acute otitis media on Canadian families.

P. De Wals, È. Dubé, M. Ouakki, 2011, Canadian family physician Medecin de famille canadien.

Quality of life of children and their caregivers during an AOM episode: development and use of a telephone questionnaire

P. De Wals, È. Dubé, M. Ouakki, 2010, Health and quality of life outcomes.

Frequency of births with potentially avoidable serious chromosomal anomalies in EEC countries, 1979-1982.

H. Dolk, G. T. te Meerman, P. De Wals, 1988, Journal of epidemiology and community health.

Reviews examining sugar-sweetened beverages and body weight: correlates of their quality and conclusions.

P. De Wals, Y. Le Bodo, José Massougbodji, 2014, The American journal of clinical nutrition.

Pneumonia After Implementation of the Pneumococcal Conjugate Vaccine Program in the Province of Quebec, Canada

P. De Wals, M. Douville-Fradet, É. Fortin, 2008, The Pediatric infectious disease journal.

Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Invasive Disease Caused by Serotype 3 in Children: A Systematic Review and Meta-analysis of Observational Studies

P. De Wals, B. Gessner, S. Pelton, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Pattern and correlates of public support for public health interventions to reduce the consumption of sugar-sweetened beverages

P. De Wals, A. Belanger-Gravel, S. Desroches, 2019, Public Health Nutrition.

Protection against omicron (B.1.1.529) BA.2 reinfection conferred by primary omicron BA.1 or pre-omicron SARS-CoV-2 infection among health-care workers with and without mRNA vaccination: a test-negative case-control study

D. Skowronski, P. De Wals, M. Brisson, 2022, The Lancet Infectious Diseases.

Could seasonal influenza vaccination influence COVID-19 risk?

P. De Wals, P. Wals, M. Divangahi, 2020, medRxiv.

Correlates of care quality in long-term care facilities: a multilevel analysis.

P. De Wals, M. Dubois, P. Wals, 1999, The journals of gerontology. Series B, Psychological sciences and social sciences.

Relationship between regulatory status, quality of care, and three-year mortality in Canadian residential care facilities: a longitudinal study.

P. De Wals, G. Bravo, M. Dubois, 2002, Health services research.

Promoting vaccination in maternity wards ─ motivational interview technique reduces hesitancy and enhances intention to vaccinate, results from a multicentre non-controlled pre- and post-intervention RCT-nested study, Quebec, March 2014 to February 2015

P. De Wals, È. Dubé, C. Quach, 2019, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Promoting vaccination in the province of Québec: the PromoVaQ randomized controlled trial protocol

P. De Wals, È. Dubé, D. Gagnon, 2019, BMC Public Health.

Uptake of Pneumococcal Conjugate Vaccine: Methodological Issues in Measurement and Impact of Publicly Funded Programs

P. De Wals, M. Guay, M. Ouakki, 2009, Canadian journal of public health = Revue canadienne de sante publique.

Kingdon’s Multiple Streams Framework and the Analysis of Decision-Making Processes Regarding Publicly-Funded Immunization Programs.

P. De Wals, D. Béland, Maria-Eugenia Espinoza-Moya, 2019, Expert review of vaccines.

Impact of pneumococcal vaccines use on invasive pneumococcal disease in Nunavik (Quebec) from 1997 to 2010

B. Lefebvre, P. De Wals, J. Proulx, 2014, International journal of circumpolar health.

Cost-effectiveness of a 3-dose pneumococcal conjugate vaccine program in the province of Quebec, Canada.

P. De Wals, L. Erickson, J. Pépin, 2009, Vaccine.

Investigation of clusters of adverse reproductive outcomes, an overview

P. De Wals, 1999, European Journal of Epidemiology.

Antibody kinetics among 8-10 years old respondents to hepatitis B vaccination in a low endemic country and the effect of a booster dose given 5 or 10 years later.

P. De Wals, G. De Serres, V. Gilca, 2009, Vaccine.

Effectiveness of serogroup C meningococcal polysaccharide vaccine: results from a case-control study in Quebec.

P. De Wals, J. Boivin, G. De Serres, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Immunization strategies for the control of serogroup C meningococcal disease in developed countries

P. De Wals, 2006, Expert review of vaccines.

Concept Analysis of Pregnancy Planning Drawn from Women of Childbearing Age

Pascale Morin, H. Payette, D. St-Cyr-Tribble, 2001 .

Cost-Effectiveness of a Lottery for Increasing Physicians’ Responses to a Mail Survey

P. De Wals, F. Milord, G. Baron, 2001, Evaluation & the health professions.

Should university students be vaccinated against meningococcal disease in Canada?

P. De Wals, 2004, The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses.

Vaccinating first-year college students living in dormitories for Meningococcal disease: an economic analysis.

M. Meltzer, P. De Wals, L. Erickson, 2002, American journal of preventive medicine.

Increase of invasive pneumococcal disease in children temporally associated with RSV outbreak in Quebec: a time-series analysis

B. Lefebvre, P. De Wals, C. Quach, 2023, Lancet regional health. Americas.

Declining rate of neural tube defects in three eastern counties of Ireland: 1979-1984.

H. Dolk, P. De Wals, A. Radic, 1987, Irish medical journal.

Epidemiology and Control of Meningococcal Disease in Canada: A Long, Complex, and Unfinished Story

P. De Wals, 2019, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

Cost-effectiveness of immunization strategies for the control of serogroup C meningococcal disease.

P. De Wals, M. Guay, L. Erickson, 2004, Vaccine.

Antibody and immune memory persistence after vaccination of preadolescents with low doses of recombinant hepatitis B vaccine

P. De Wals, G. De Serres, G. Deceuninck, 2010, Human vaccines.

Longitudinal study of asymptomatic meningococcal carriage in two Belgian populations of schoolchildren.

A Bouckaert, M F Lechat, P. De Wals, 1983, The Journal of infection.

Can BCG be useful to mitigate the COVID-19 pandemic? A Canadian perspective

P. De Wals, D. Menzies, M. Divangahi, 2020, Canadian Journal of Public Health.

Does BCG provide long-term protection against SARS-CoV-2 infection? A case–control study in Quebec, Canada

P. De Wals, L. Valiquette, M. Parent, 2021, Vaccine.

Trends of Hepatitis A hospitalization and risk factors in Quebec, Canada, between 1990 and 2003

P. De Wals, M. Canuel, G. De Serres, 2007, BMC infectious diseases.

Evaluation of serogroup C and ACWY meningococcal vaccine programs: projected impact on disease burden according to a stochastic two-strain dynamic model.

C. Bauch, P. De Wals, N. Demarteau, 2015, Vaccine.

Pregnancy planning and folic acid supplement use: results from a survey in Quebec.

Pascale Morin, D. St-Cyr-Tribble, T. Niyonsenga, 2002, Preventive medicine.

Risk of Guillain-Barré syndrome following H1N1 influenza vaccination in Quebec.

P. De Wals, D. Brunet, G. De Serres, 2012, JAMA.

Single-dose mRNA vaccine effectiveness against SARS-CoV-2 in healthcare workers extending 16 weeks post-vaccination: a test-negative design from Quebec, Canada

D. Skowronski, P. De Wals, M. Brisson, 2021, medRxiv.

Individual and School Correlates of Adolescent Leisure Time Physical Activity in Quebec, Canada

P. De Wals, A. Lebel, José Massougbodji, 2018, International journal of environmental research and public health.

The Quebec experience in promoting healthy lifestyles and preventing obesity: how can we do better?

P. De Wals, Y. Le Bodo, P. Wals, 2017, Obesity reviews : an official journal of the International Association for the Study of Obesity.

Evaluation of routine ultrasound examination for the prenatal diagnosis of malformation.

A Billiet, P. De Wals, F Lys, 1989, European journal of obstetrics, gynecology, and reproductive biology.

B. Lefebvre, P. De Wals, R. Tsang, 2015, BMC Microbiology.

Complications of meningococcal disease in college students.

P. De Wals, L. Erickson, P. Wals, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Middle ear abnormalities at age 5 years in relation with early onset otitis media and number of episodes, in the Inuit population of Nunavik, Quebec, Canada

P. De Wals, H. Ayukawa, J. Proulx, 2019, International journal of circumpolar health.

A method for the follow-up of clusters of adverse reproductive outcomes

T. Niyonsenga, P. De Wals, 1999, European Journal of Epidemiology.

A Prospective Evaluation of the Charlson Comorbidity Index for Use in Long‐Term Care Patients

P. De Wals, G. Bravo, M. Dubois, 2002, Journal of the American Geriatrics Society.

Evaluation of information systems for the surveillance of congenital malformations.

P. De Wals, M. Lechat, J. Weatherall, 1984, International journal of epidemiology.

Economic analysis of the 1992-1993 mass immunization campaign against serogroup C meningococcal disease in Quebec.

P. De Wals, L. Erickson, 2002, Vaccine.

Factors associated with HPV vaccination among adult women in Quebec

P. De Wals, È. Dubé, G. Deceuninck, 2013, Human vaccines & immunotherapeutics.

Distribution of single organ malformations in European populations. EUROCAT Working Group.

E. Calzolari, C. Stoll, H. Dolk, 1995, Annales de genetique.

Benefits and costs of immunization of children with pneumococcal conjugate vaccine in Canada.

P. De Wals, T. Tam, M. Guay, 2003, Vaccine.

Validity of death and stillbirth certificates and hospital discharge summaries for the identification of neural tube defects in Quebec City.

P. De Wals, A. Bastide, Fassiatou Tairou, 2006, Chronic diseases in Canada.

International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines.

M. Sturkenboom, P. De Wals, S. Chuang, 2013, Vaccine.

Epidemiological evidence for immunity following Trypanosoma brucei gambiense sleeping sickness.

T. Niyonsenga, P. De Wals, F. Milord, 1995, Transactions of the Royal Society of Tropical Medicine and Hygiene.